Several factors influence your personal results: your starting weight, how well you tolerate the medication (and therefore which dose you can reach), your diet and exercise habits, and your individual metabolism
For comparative pharmacology, the molar pairing matters more than the mass pairing
Sasha Perez Legislator Is there like a specific deadline in place in order for them to meet some of those requirements
Where Ozempic (semaglutide) is a pure GLP-1 receptor agonist, Retatrutide is a triple agonist working on: GLP-1 improves insulin sensitivity, reduces appetite, slows stomach emptying GIP (Glucose-dependent insulinotropic peptide) enhances insulin secretion, may preserve beta cells, and appears to help prevent the dreaded weight plateau seen with GLP-1 alone Glucagon receptor promotes fat metabolism and increases energy expenditure This means that not only does Retatrutide regulate blood sugar and suppress appetite like Ozempic it also burns more fat and preserves more muscle while you lose weight
80+ Biomarker Baseline Panel Full thyroid, fasting insulin, HbA1c, hormones, and inflammation markers measured before prescribing, so root causes of weight gain get treated too